Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AML.
Blood
; 113(17): 4052-62, 2009 Apr 23.
Article
in En
| MEDLINE
| ID: mdl-19144991
Full text:
1
Database:
MEDLINE
Therapeutic Methods and Therapies TCIM:
Terapias_biologicas
/
Aromoterapia
Main subject:
Leukemia, Myeloid, Acute
/
Signal Transduction
/
Gene Expression Regulation, Neoplastic
/
Fms-Like Tyrosine Kinase 3
/
STAT3 Transcription Factor
/
Microtubule-Associated Proteins
Type of study:
Prognostic_studies
Language:
En
Journal:
Blood
Year:
2009
Type:
Article
Affiliation country:
Singapore